Presbyopia Epidemiology Forecast to 2030 – Focus on United States, Japan, Germany, Italy, France, United Kingdom, and Spain – ResearchAndMarkets.com | Financial Buzz

Presbyopia Epidemiology Forecast to 2030 – Focus on United States, Japan, Germany, Italy, France, United Kingdom, and Spain – ResearchAndMarkets.com

The “Presbyopia – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.

This ‘Presbyopia – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Presbyopia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Presbyopia Diagnosis

Presbyopia can be diagnosed by an optometrist, ophthalmologist, or physician, who takes a complete medical history to determine the extent of the vision problem. The doctor also tests the vision by having the patient read the text at a typically comfortable distance. If the diagnosis of presbyopia is confirmed, the doctor may perform a test to determine the extent of the focusing problem and the appropriate lens prescription.

In this test, the doctor asks the patient to look through corrective lenses and continues to increase the magnification power until the words on the page are clear and comfortable enough to be read by the patient. A thorough assessment of the health of the eyes and associated structures is an integral component of the comprehensive adult eye and vision examination. This examination can lead to the diagnosis of systemic diseases and disorders that have ocular manifestations.

Epidemiology Perspective

The Presbyopia epidemiology division provides insights about historical and current Presbyopia patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In the year 2020, the total prevalent case of Presbyopia was 286,994,105 cases in the 7MM which are expected to grow during the forecast period, i.e., 2021-2030.

The disease epidemiology covered in the report provides historical as well as forecasted Presbyopia epidemiology [segmented as Total Prevalent Cases of Presbyopia, Total Diagnosed Cases of Presbyopia, Total Age-specific Cases of Presbyopia, Gender-specific Cases of Presbyopia, Severity-specific Cases of Presbyopia, and Total Treated cases of Presbyopia] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Presbyopia Epidemiology

Estimates show that the highest cases of Presbyopia in the 7MM were in the United States, followed by Germany, Japan, Italy, France, the United Kingdom, and Spain in 2020.

  • In the United States, the total number of prevalent cases of Presbyopia was 117,369,699 cases in the year 2020 which are expected to grow during the forecast period, i.e., 2021-2030.
  • In the year 2020, the total prevalent cases of Presbyopia were 134,726,460 cases in EU-5 which are expected to grow during the forecast period, i.e., 2021-2030.
  • In Japan, the total number of prevalent cases of Presbyopia was 34,897,947 cases in the year 2020 which are expected to grow during the forecast period, i.e., 2021-2030.

Study Period:

  • In the 7MM, the total diagnosed cases of Presbyopia was 246,336,607 cases in the year 2020, which will probably rise during the forecast period, i.e., 2021-2030.
  • In the 7MM, the total gender-specific cases of Presbyopia were 98,534,643 for males and 147,801,964 for females in the year 2020.
  • In the 7MM, the total age-specific cases of Presbyopia were 70,036,878, 80,546,882, 58,274,618, and 37,478,227 cases for the age group less than 60 years, 60-69, 70-79, and ?80 years, respectively in 2020.
  • In the 7MM, the total severity-specific cases of Presbyopia were 49,267,321 and 197,069,285 for mild cases and moderate to severe cases, respectively in the year 2020.
  • In the 7MM, the total treated cases of Presbyopia was 197,069,285 cases in the year 2020, which will probably rise during the forecast period, i.e., 2021-2030.

Key Topics Covered:

1. Key Insights

2. Report Introduction

3. Executive Summary of Presbyopia

4. Epidemiology Methodology

5. Disease Background and Overview

5.1. Introduction

5.1.1. Signs and Symptoms of Presbyopia

5.1.2. Difference between Presbyopia and Hyperopia

5.1.3. Risk Factors and Causes of Presbyopia

5.1.4. Pathophysiology of Presbyopia

5.1.5. Complications of Presbyopia

5.2. Diagnosis of Presbyopia

5.3. Patient History

5.4. Ocular Examination

5.4.1. Visual Acuity

5.4.2. Keratometry/Topography

5.4.3. Refraction

5.4.4. Binocular Vision and Accommodation

5.5. Supplemental Testing

5.6. Eye health evaluation

5.7. Recommended eye examination frequency for pediatric patients and adults

5.8. Differential Diagnosis

6. Early Detection and Prevention of Presbyopia

7. Epidemiology and Patient Population

7.1. Key Findings

7.2. Epidemiology of Presbyopia

7.3. Epidemiology Scenario: 7MM

7.3.1. Total Prevalent Cases of Presbyopia

7.3.2. Total Diagnosed Cases of Presbyopia

7.3.3. Total Age-specific Cases of Presbyopia

7.3.4. Gender-specific Cases of Presbyopia

7.3.5. Severity-specific Cases of Presbyopia

7.3.6. Total Treated Cases of Presbyopia

8. The United States

8.1. Total Prevalent Cases of Presbyopia

8.2. Total Diagnosed Cases of Presbyopia

8.3. Total Age-specific Cases of Presbyopia

8.4. Gender-specific Cases of Presbyopia

8.5. Severity-specific Cases of Presbyopia

8.6. Total Treated Cases of Presbyopia

9. EU-5

9.1. Germany

9.2. France

9.3. Italy

9.4. Spain

9.5. The United Kingdom

10. Japan

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/7yrq5h

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900